Trial Profile
A study to Evaluate the Risk of Proximal Tubular Dysfunction and Osteoporosis in Chronic Hepatitis B (CHB) Patients who were Treatment Naive or Treated with Either Tenofovir Disoproxil Fumarate and Entecavir
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Dec 2015
Price :
$35
*
At a glance
- Drugs Entecavir (Primary) ; Tenofovir disoproxil fumarate (Primary)
- Indications Hepatitis B
- Focus Adverse reactions
- 16 Dec 2015 New trial record